Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

New medications could improve treatment for severe alopecia areata in Australia.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Pigmented vellus and upright regrowing hairs predict hair regrowth in severe alopecia.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Baricitinib is effective and safe for treating severe alopecia areata.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.